reports
- ABGSC Renewable Energy Research
- Åsne Holsen
- Daniel Vårdal Haugland
Nokia Corporation: Repurchase of own shares on 06.05.2024
Nokia Corporation: Repurchase of own shares on 06.05.2024 Nokia CorporationStock Exchange Release06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to...
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million
HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead Underwriters (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its pre...
- ABGSC Shipping & Transport Research
- Oliver Dunvold
- Petter Haugen
Moody's Ratings rates Graphic Packaging's new notes Ba2; outlook stabl...
Moody's Ratings (Moody's) assigned a Ba2 rating to Graphic Packaging International, LLC's (Graphic Packaging) proposed $500 million backed senior unsecured notes due in 2032. Proceeds from the notes will be used to partially repay borrowings under the revolver, which have increased due to the maturi...
- ABGSC Shipping & Transport Research
- Oliver Dunvold
- Petter Haugen
Trading in Novo Nordisk shares by board members, executives and associ...
Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated perso...
Moody's Ratings affirms Emerson College's (MA) Baa2 ratings; outlook s...
Moody's Ratings (Moody's) has affirmed Emerson College, MA's Baa2 issuer and revenue bond ratings. Roughly $497 million of total debt was outstanding as of June 30, 2023. The outlook is stable. RATINGS RATIONALE The affirmation of Emerson's Baa2 issuer rating reflects strong expense management...
Moody's Ratings says B2 rating of Freedom Mortgage Holdings LLC's seni...
Moody's Ratings (Moody's) said that Freedom Mortgage Holdings LLC's (Freedom) B1 corporate family rating (CFR) and B2 senior unsecured rating were unaffected by the company's decision to increase its existing senior unsecured notes due in 2029 by $300 million. Freedom's rating outlook is stable. T...
Novo Nordisk A/S - share repurchase programme
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 2.2 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules”). The purpose of the programme is to reduce the company’s share capital and to meet o...
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo ...
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The transaction is part of Novo Nordisk A/S’ 2024 share repurchase programme of up to a total of DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. The transaction price is DKK 860.02 per share and has been calculated as the three-day volume we...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.